Privium-Fund-Management-Bv

AI_NATIVE detailed information: This accession holds the following tickers:[
  "AXSM",
  "SE",
  "KRYS",
  "ARQT",
  "ACAD",
  "ALXO",
  "SNOW",
  "ARWR",
  "ALNY",
  "AIG",
  "RXRX",
  "SWTX",
  "NE",
  "RCKT",
  "TSHA",
  "FATE",
  "AUTL",
  "LXEO",
  "PRQR",
  "SA",
  null,
  "IONS",
  "EMX",
  "NVDA",
  "PLTR",
  "PFE",
  "MRK",
  "SHOP",
  "RNA",
  "MRNA",
  "SD",
  "FDMT",
  "NTLA",
  null,
  "QURE",
  "DYN",
  "VRTX",
  "WVE",
  "ROIV",
  "AMZN",
  "ABEV",
  "URGN",
  "VAL",
  "VYGR",
  "ZLAB",
  "NOV",
  "SBSW",
  "RARE",
  "IMVT",
  "SPOT",
  "PAAS",
  "NET",
  "CPNG",
  "CRSP",
  "TSLA",
  "MGTX"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-09
Total Holdings: 56
Total Value: 383644269
Accession Number: 0001754960-25-000288
Form Type: 13F-HR
CIK: privium-fund-management-bv
Manager Name: Privium-Fund-Management-Bv

Data Enrichment

96% identified

54 identified2 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

56 positions • $383.6M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 3 of 3

Sort by:

PAN AMERICAN SILVER CORP

PAAS|697900108

Shares:21.3K

Value:$549.8K

% of Portfolio:0.1% ($549.8K/$383.6M)

SEABRIDGE GOLD INC

SA|811916105

Shares:44.1K

Value:$514.3K

% of Portfolio:0.1% ($514.3K/$383.6M)

EMX Royalty Corp

EMX|26873J107

Shares:217.0K

Value:$442.6K

% of Portfolio:0.1% ($442.6K/$383.6M)

92859G608

Shares:192.5K

Value:$436.9K

% of Portfolio:0.1% ($436.9K/$383.6M)

4D Molecular Therapeutics, Inc.

FDMT|35104E100

Shares:131.0K

Value:$423.1K

% of Portfolio:0.1% ($423.1K/$383.6M)

Intellia Therapeutics, Inc.

NTLA|45826J105

Shares:58.7K

Value:$417.4K

% of Portfolio:0.1% ($417.4K/$383.6M)

85208P303

Shares:12.1K

Value:$393.0K

% of Portfolio:0.1% ($393.0K/$383.6M)

Autolus Therapeutics plc

AUTL|05280R100

Shares:251.7K

Value:$390.1K

% of Portfolio:0.1% ($390.1K/$383.6M)

Noble Corp plc

NE|G65431127

Shares:14.3K

Value:$338.6K

% of Portfolio:0.1% ($338.6K/$383.6M)

ALX ONCOLOGY HOLDINGS INC

ALXO|00166B105

Shares:509.1K

Value:$317.1K

% of Portfolio:0.1% ($317.1K/$383.6M)

Dyne Therapeutics, Inc.

DYN|26818M108

Shares:27.6K

Value:$288.3K

% of Portfolio:0.1% ($288.3K/$383.6M)

SANDRIDGE ENERGY INC

SD|80007P869

Shares:23.3K

Value:$266.1K

% of Portfolio:0.1% ($266.1K/$383.6M)

Taysha Gene Therapies, Inc.

TSHA|877619106

Shares:134.9K

Value:$187.5K

% of Portfolio:0.0% ($187.5K/$383.6M)

Sibanye Stillwater Ltd

SBSW|82575P107

Shares:34.0K

Value:$155.9K

% of Portfolio:0.0% ($155.9K/$383.6M)

FATE THERAPEUTICS INC

FATE|31189P102

Shares:109.0K

Value:$86.1K

% of Portfolio:0.0% ($86.1K/$383.6M)

Voyager Therapeutics, Inc.

VYGR|92915B106

Shares:21.6K

Value:$73.2K

% of Portfolio:0.0% ($73.2K/$383.6M)

Instrument	Shares		Other Manager	Value	% of Portfolio
PAN AMERICAN SILVER CORP(PAAScusip697900108)	21.3K	QoQ 0.00% (+0) YoY -28.81% (-8.6K)	All Managers (Combined)	$549.8K	0.1% ($549.8K/$383.6M)	QoQ +27.74% (+$119.4K) YoY +21.93% (-$98.9K)
SEABRIDGE GOLD INC(SAcusip811916105)	44.1K	QoQ +22.47% (+8.1K) YoY +15.35% (-5.9K)	All Managers (Combined)	$514.3K	0.1% ($514.3K/$383.6M)	QoQ +25.26% (+$103.7K) YoY -10.96% (-$63.3K)
EMX Royalty Corp(EMXcusip26873J107)	217.0K	QoQ 0.00% (+0) YoY NEW(+217.0K)	All Managers (Combined)	$442.6K	0.1% ($442.6K/$383.6M)	QoQ +17.91% (+$67.3K) YoY NEW(+$442.6K)
(cusip92859G608)✕	192.5K	QoQ +65.19% (+76.0K) YoY NEW(+192.5K)	All Managers (Combined)	$436.9K	0.1% ($436.9K/$383.6M)	QoQ +119.29% (+$237.7K) YoY NEW(+$436.9K)
4D Molecular Therapeutics, Inc.(FDMTcusip35104E100)	131.0K	QoQ +8.26% (-10.0K) YoY +322.58% (-100.0K)	All Managers (Combined)	$423.1K	0.1% ($423.1K/$383.6M)	QoQ -37.21% (-$250.8K) YoY -57.15% (-$564.5K)
Intellia Therapeutics, Inc.(NTLAcusip45826J105)	58.7K	QoQ +111.87% (+31.0K) YoY +559.28% (+49.8K)	All Managers (Combined)	$417.4K	0.1% ($417.4K/$383.6M)	QoQ +29.19% (+$94.3K) YoY +70.39% (+$172.4K)
(cusip85208P303)✕	12.1K	QoQ +17.88% (-1.8K) YoY NEW(+12.1K)	All Managers (Combined)	$393.0K	0.1% ($393.0K/$383.6M)	QoQ -5.12% (-$21.2K) YoY NEW(+$393.0K)
Autolus Therapeutics plc(AUTLcusip05280R100)	251.7K	QoQ +8.63% (-20.0K) YoY +402.76% (+201.6K)	All Managers (Combined)	$390.1K	0.1% ($390.1K/$383.6M)	QoQ -28.34% (-$154.3K) YoY +22.14% (+$70.7K)
Noble Corp plc(NEcusipG65431127)	14.3K	QoQ +35.74% (+3.8K) YoY +216.85% (+9.8K)	All Managers (Combined)	$338.6K	0.1% ($338.6K/$383.6M)	QoQ +2.45% (+$8.1K) YoY +54.86% (+$120.0K)
ALX ONCOLOGY HOLDINGS INC(ALXOcusip00166B105)	509.1K	QoQ 0.00% (-0) YoY NEW(+509.1K)	All Managers (Combined)	$317.1K	0.1% ($317.1K/$383.6M)	QoQ -62.69% (-$533.0K) YoY NEW(+$317.1K)
Dyne Therapeutics, Inc.(DYNcusip26818M108)	27.6K	QoQ +35.35% (-7.2K) YoY NEW(+27.6K)	All Managers (Combined)	$288.3K	0.1% ($288.3K/$383.6M)	QoQ -39.90% (-$191.5K) YoY NEW(+$288.3K)
SANDRIDGE ENERGY INC(SDcusip80007P869)	23.3K	QoQ 0.00% (-0) YoY NEW(+23.3K)	All Managers (Combined)	$266.1K	0.1% ($266.1K/$383.6M)	QoQ -2.47% (-$6.8K) YoY NEW(+$266.1K)
Taysha Gene Therapies, Inc.(TSHAcusip877619106)	134.9K	QoQ 0.00% (-0) YoY NEW(+134.9K)	All Managers (Combined)	$187.5K	0.0% ($187.5K/$383.6M)	QoQ -19.65% (-$45.9K) YoY NEW(+$187.5K)
Sibanye Stillwater Ltd(SBSWcusip82575P107)	34.0K	QoQ 0.00% (+0) YoY NEW(+34.0K)	All Managers (Combined)	$155.9K	0.0% ($155.9K/$383.6M)	QoQ +38.78% (+$43.6K) YoY NEW(+$155.9K)
FATE THERAPEUTICS INC(FATEcusip31189P102)	109.0K	QoQ +25.31% (-22.0K) YoY NEW(+109.0K)	All Managers (Combined)	$86.1K	0.0% ($86.1K/$383.6M)	QoQ -39.99% (-$57.4K) YoY NEW(+$86.1K)
Voyager Therapeutics, Inc.(VYGRcusip92915B106)	21.6K	QoQ NEW(+21.6K) YoY NEW(+21.6K)	All Managers (Combined)	$73.2K	0.0% ($73.2K/$383.6M)	QoQ NEW(+$73.2K) YoY NEW(+$73.2K)